A Clinical Study of CD19 CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases

NCT06318533 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: anti-CD19 CAR NK cells

Sponsor

YANRU WANG

Collaborators

[object Object]